Rhythm Pharmaceuticals, Inc. (RYTM) quarterly cash flow statement — complete operating, investing & financing history
Rhythm Pharmaceuticals, Inc. (RYTM) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -53.34M | -44.19M | -25.39M | -26.62M | -23.31M | -40.35M | -18.84M | -25.21M | -29.08M | -40.74M | -29.38M | -29.25M | -41.09M | -36.43M | -34M | -46.99M | -38.81M | -53.63M | -40.47M | -40.16M |
| Operating CF Margin % | -74.85% | -73.5% | -44.35% | -51.9% | -48.07% | -123.38% | -45.05% | -75.83% | -99.99% | -156.9% | -121.25% | -129.98% | -213.78% | -317.67% | -386.8% | -1096.8% | -428.07% | -3580.24% | -2227.41% | -3906.61% |
| Operating CF Growth % | -128.79% | -9.5% | -34.73% | -5.58% | 19.82% | 0.96% | 35.86% | 13.8% | 29.24% | -11.83% | 13.58% | 37.75% | -5.88% | 32.07% | 15.99% | -17% | -21.89% | -59.95% | -38.97% | -48.58% |
| Net Income | -104.94M | -55.64M | -47.51M | -52.9M | -46.63M | -49.5M | -43.29M | -43.68M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M | -52.18M | -42.49M | -40.86M | -45M | -52.76M | -42.87M | -35.11M |
| Depreciation & Amortization | 503K | 252K | 272K | 304K | 379K | 383K | 383K | 385K | 390K | 405K | 417K | 442K | 442K | 457K | 442K | 442K | 438K | 350K | 325K | 315K |
| Stock-Based Compensation | 49.16M | 23.1M | 19.27M | 18.81M | 15.88M | 12.86M | 10.56M | 11M | 10.36M | 7.77M | 8.67M | 8.61M | 8.89M | 6.38M | 5.29M | 4.8M | 5.14M | 4.61M | 4.68M | 5.27M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135K | 0 | 0 | 0 | 0 | 0 | 0 | -8.99M |
| Other Non-Cash Items | 8.3M | 5.11M | 3.27M | 4.06M | 2.54M | 3.81M | 3.3M | 2.38M | -5.42M | 94.64M | -5.75M | 7.44M | 3.49M | 6.16M | 2.88M | 3.12M | -19K | -65K | -8.05M | -63K |
| Working Capital Changes | -6.36M | -17.01M | -691K | 3.11M | 4.53M | -7.91M | 10.21M | 4.7M | -2.15M | -2.19M | 8.91M | -1.58M | -7.34M | 2.75M | -116K | -14.48M | 636K | -5.76M | 5.45M | -1.58M |
| Change in Receivables | -14.33M | -8.11M | 6.17M | -6.6M | -7.83M | 687K | 794K | -1.71M | -2.9M | 172K | -178K | -710K | -5.71M | -1.89M | -12.28M | -598K | -1.71M | 0 | 0 | 0 |
| Change in Inventory | -5.43M | -3.09M | -4.93M | -2.45M | 479K | -575K | -4.85M | -1.9M | -3.49M | 117K | -862K | -1.58M | -690K | -2.57M | 0 | 5K | -1.58M | 0 | 0 | 0 |
| Change in Payables | 10.84M | -5.62M | 1.25M | 11.02M | 13.26M | -3.63M | 15.18M | 7.51M | 482K | -1.25M | 0 | 4.09M | 661K | 5.17M | 15.71M | -12.57M | -1.55M | -53K | 12.92M | 5.99M |
| Cash from Investing | 71.06M | 57.05M | 30.35M | -246.35M | 54.03M | 24.81M | 21.16M | -90.82M | -8.56M | 30.05M | 22.64M | -94.96M | 48.19M | 18.46M | -40.77M | -39.7M | 35.98M | 72.52M | 7.25M | 62.78M |
| Capital Expenditures | 0 | 0 | -953K | 0 | 0 | 0 | 0 | -500K | 0 | -40M | 1K | -273K | -875K | -47K | 1K | -95K | -60K | -127K | -68K | -106K |
| CapEx % of Revenue | - | - | 1.66% | - | - | - | - | 1.5% | - | 154.04% | 0% | 1.21% | 4.55% | 0.41% | 0.01% | 2.22% | 0.66% | 8.48% | 3.74% | 10.31% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 875K | 0 | 0 | 39.6M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -40M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -875K | -4.52M | 0 | -39.6M | -4M | 0 | 7M | 0 |
| Cash from Financing | -6.57M | -5.4M | -2.95M | 189.3M | -889K | 32.5M | 38.33M | 2.49M | 146.18M | 4.24M | 2.42M | 73.04M | -965K | -133K | 17.36M | 158.56M | 37.5M | 399K | 100K | 413K |
| Debt Issued (Net) | -11.2M | -4.29M | -5.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 14.35M | 7.35M | 2.45M | 188.66M | 0 | 34.03M | 39.15M | 0 | 0 | 0 | 0 | 50.84M | 341K | 0 | 14.14M | 116.97M | 0 | 0 | -5K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -9.71M | -8.46M | 0 | 645K | -889K | -1.53M | -818K | 2.49M | 146.18M | 4.24M | 2.42M | 24.37M | -1.31M | -133K | 3.23M | 41.59M | 37.5M | 399K | 105K | 413K |
| Net Change in Cash | 11.39M | 7.84M | 2.22M | -83.36M | 29.55M | 16.96M | 41.62M | -114.15M | 108.24M | -6.52M | -4.51M | -51.09M | 6.02M | -18.02M | -57.41M | 71.88M | 34.67M | 19.29M | -33.12M | 23.03M |
| Free Cash Flow | -53.34M | -44.19M | -26.34M | -26.62M | -23.31M | -40.35M | -18.84M | -25.21M | -29.08M | -80.74M | -29.38M | -29.25M | -41.97M | -36.48M | -34M | -47.08M | -42.87M | -53.76M | -40.54M | -40.27M |
| FCF Margin % | -74.85% | -73.5% | -46.01% | -51.9% | -48.07% | -123.38% | -45.05% | -75.83% | -99.99% | -310.94% | -121.24% | -129.99% | -218.33% | -318.07% | -386.79% | -1099.02% | -472.85% | -3588.72% | -2231.15% | -3916.93% |
| FCF Growth % | -128.79% | -9.5% | -39.78% | -5.58% | 19.82% | 50.03% | 35.86% | 13.8% | 30.71% | -121.33% | 13.58% | 37.87% | 2.11% | 32.14% | 16.13% | -16.93% | -15.59% | -60.27% | -38.8% | -48.25% |
| FCF per Share | -0.78 | -0.65 | -0.39 | -0.41 | -0.37 | -0.64 | -0.31 | -0.41 | -0.48 | -1.34 | -0.50 | -0.51 | -0.74 | -0.64 | -0.60 | -0.92 | -0.85 | -1.07 | -0.81 | -0.80 |
| FCF Conversion (FCF/Net Income) | 1.08x | 0.79x | 0.53x | 0.50x | 0.50x | 0.82x | 0.44x | 0.58x | 0.90x | 0.29x | 0.71x | 0.66x | 0.88x | 0.70x | 0.80x | 1.15x | 0.86x | 1.02x | 0.94x | 1.14x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |